companydata.dkDATAPHARM A/S: Financial statements 2023
CVR: 72323211
DATAPHARM A/S (CVR 72323211) has filed annual accounts for 2023. In 2023, the company reported a net result of DKK 703,717 compared with DKK 840,867 the year before. Equity amounted to DKK 10,442,254. The solvency ratio was 76.9%.
- Profit/Loss
- 703,717 kr.
- Equity
- 10,442,254 kr.
- Total Assets
- 13,570,195 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | - | 704 t. | 10.4 mio. | 0 |
| 2022 | - | - | 841 t. | 9.7 mio. | 0 |
| 2021 | - | - | 602 t. | 8.9 mio. | 0 |
| 2020 | - | - | 305 t. | 8.3 mio. | 0 |
| 2019 | - | - | -2.6 mio. | 8 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
DATAPHARM A/S has published its annual report for 2022. The net result was DKK 840,867.
As of April 20, 2023, Helle Steen Sørensen has left the board of directors of DATAPHARM A/S.
About DATAPHARM A/S
DATAPHARM A/S is a Danish company of the type Aktieselskab based in København K, founded in 1983. The company is registered under the industry Computerprogrammering. The management consists of Henrik Bruun. The company is owned by D.A. INVEST OG UDVIKLING A/S. The company has 4 employees. In 2025, the company reported a net result of DKK 657,407 compared with DKK 650,613 the year before. Equity amounted to DKK 11,750,274.